The effect of combined angiotensin-converting enzyme inhibition and calcium antagonism on allograft coronary vasculopathy validated by intravascular ultrasound

Journal of Heart and Lung Transplantation

Volumn 24, Issue 8, 2005, Pages 1033-1038

  Erinc, Kursad ^a   Yamani, Mohamad H ^a   Starling, Randall C ^a   Crowe, Tim ^a   Hobbs, Robert ^a   Bott Silverman, Corinne ^a   Rincon, Gustavo ^a   Young, James B ^a   Feng, Jingyuan ^a   Cook, Daniel J ^a   Smedira, Nicholas ^a   Tuzcu, E Murat ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; AZATHIOPRINE; CALCIUM ANTAGONIST; CYCLOSPORIN A; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FELODIPINE; FOSINOPRIL; LISINOPRIL; MYCOPHENOLIC ACID; NIFEDIPINE; PREDNISONE; QUINAPRIL; RAMIPRIL; RAPAMYCIN; TACROLIMUS;

ADULT; AGED; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; CARDIAC ALLOGRAFT VASCULOPATHY; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEART TRANSPLANTATION; HUMAN; HYPERTENSION; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; RISK FACTOR;

AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; CASE-CONTROL STUDIES; CORONARY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE COMPLICATIONS; PROBABILITY; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 23744459380     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2004.06.005     Document Type: Article

References (28)

1. E. Arbustini, B. Dal Pello, P. Morbini Factors increasing the risk of allograft disease in heart transplant recipients G Ital Cardiol 27 1997 985 999
2. M.I. Hertz, D.O. Taylor, E.P. Trulock The registry of the International Society for Heart and Lung Transplantation Nineteenth Official Report-2002 J Heart Lung Transplant 21 2002 950 970
3. S.M. Hollenberg, L.W. Klein, J.E. Parrillo Changes in coronary endothelial function predict progression of allograft vasculopathy after heart transplantation J Heart Lung Transplant 23 2004 265 271
4. A. Konig, C.H. Spes, T.M. Schiele Coronary Doppler measurements do not predict progression of cardiac allograft vasculopathy analysis by serial intracoronary Doppler, dobutamine stress echocardiography, and intracoronary ultrasound J Heart Lung Transplant 21 2002 902 905
5. M.H. Yamani, E.M. Tuzcu, R.C. Starling Computerized scoring of histopathology for predicting coronary vasculopathy, validated by intravascular ultrasound J Heart Lung Transplant 21 2002 850 859
6. S. Brozena, M.R. Johnson, H. Ventura Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation. Results of a prospective, randomized multicenter trial JAMA 27 1996 1707 1712
7. L.C. Paul Calcium channel blockers and ACE inhibitors in the prevention of graft vasculopathy J Heart Lung Transplant 19 2000 409 413
8. M. Richter, H. Richter, M. Skupin Do vascular compartments differ in the development of chronic rejection? AT1 blocker candesartan versus ACE blocker enalapril in an experimental heart transplant model J Heart Lung Transplant 20 2001 1092 1098
9. J. Kobayashi, S.E. Crawford, C.L. Backer Captopril reduces graft coronary artery disease in a rat heterotopic transplant model Circulation 88 suppl II 1993 286 290
10. L.C. Paul, A. Davidoff, H. Benediktsson Cardiac allograft atherosclerosis in the rat. The effect of histocompatibility factors, cyclosporine, and an angiotensin-converting enzyme inhibitor Transplantation 57 1994 1767 1772
11. Y. Furukawa, A. Matsumori, T. Hirozane Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserves graft status in a murine model. A comparative study with captopril Circulation 93 1996 333 339
12. J.B. Atkinson, J.H. Wudel, S.J. Hoff Amlodipine reduces graft coronary artery disease in rat heterotopic cardiac allografts J Heart Lung Transplant 12 1993 1036 1043
13. H. Takami, C.L. Backer, S.E. Crawford Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease J Heart Lung Transplant 15 1996 67 77
14. E.M. Tuzcu, R.E. Hobbs, G. Rincon Occult and frequent transmission of atherosclerotic coronary disease with cardiac transplantation. Insights from intravascular ultrasound Circulation 91 1995 1706 1713
15. M.R. Mehra, H.O. Ventura, F.W. Smart An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy Am J Cardiol 75 1995 853 854
16. J.S. Schroeder, S.Z. Gao, E.L. Alderman A preliminary study of diltiazem in the prevention of coronary artery disease in heart transplant recipients N Engl J Med 328 1993 164 170
17. A. Gheissari, T. Yokoyama, J. Hendel Diltiazem prevents accelerated graft coronary artery disease in heart transplant recipients Transplant Proc 27 1995 2625 2627
18. G.S. Mintz, S.E. Nissen, W.D. Anderson American College Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents JAMA 37 2001 1478 1492
19. M. Lassila Interaction of cyclosporine A and the renin-angiotensin system; new perspectives Curr Drug Metab 3 2002 61 71
20. L.L. Shears, N. Kawaharada, E. Tzeng Inducible nitric oxide synthase suppresses the development of allograft atherosclerosis J Clin Invest 100 1997 2035 2042
21. J. Koglin, T. Glysing-Jensen, J.S. Mudgett Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice Circulation 97 1998 2059 2065
22. J.G.B. Mancini, G.C. Henry, C. Macaya Angiotensin converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing Endothelial Dysfunction) Study Circulation 94 1996 258 265
23. V.J. Dzau, R. Pratt, G.H. Gibbons Angiotensin as local modulating factor in ventricular dysfunction and failure due to coronary artery disease Drugs 47 suppl 4 1994 1 13
24. P.R. Lichtlen, P.G. Hugenholtz, W. Rafflenbeul Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy) Cardiovasc Drugs Ther 4 Suppl 5 1990 1047 1068
25. X. Zhang, T.H. Hintze Amlodipine releases nitric oxide from canine coronary microvessels An unexpected mechanism of action of a calcium channel-blocking agent Circulation 97 1998 576 580
26. B. Pitt, R.P. Byington, C.D. Furberg Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events Circulation 102 2000 1503 1510
27. T. Godfraind, S. Salomone Calcium antagonists and endothelial dysfunction focus on nitric oxide and endothelin Cardiovasc Drug Ther 10 1996 439 446
28. F.T. Ruschitzka, G. Noll, T.F. Luscher Combination of ACE inhibitors and calcium antagonists a logical approach J Cardiovasc Pharmacol 31 suppl 2 1998 S5 S16